Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QoLESS AZA-AMLE: Azacitidine Maintenance in Elderly AML
NCT05188326Phase 3Completed
- Sponsor
- Qol-one
- Start
- Nov 2010
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azacitidine in acute myeloid leukemia (AML), sponsored by Qol-one. Started Nov 2010; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT05188326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05188326.